Cory berkland. Dr. Cory Berkland is Chairman of the Board, President, CEO, ...

Founded Date Aug 31, 2016. Founders Cory Berkland. Operating Statu

El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752-1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731-2746.Cory Berkland spun Austin, Texas-based Savara Inc. out of his University of Kansas lab in 2007 to develop aerosolized drug therapies. It's the first company wThe toll-like receptor 7 and 8 (TLR7/8) agonist Resiquimod (R848) has been recognized as a promising immunostimulator for the treatment of cutaneous cancers in multiple clinical trials. However, systemic administration of R848 often results in strong immune-related toxicities while having limited th …Alhakamy NA, Berkland CJ. Glatiramer Acetate (Copaxone®) is a Promising Gene Delivery Vector. Molecular Pharmaceutics. PMID 30865465 DOI: 10.1021/acs.molpharmaceut.8b01282 : 0.4: 2018: Xie SX, Baoum A, Alhakamy NA, Berkland CJ. Calcium enhances gene expression when using low molecular weight poly-L-lysine delivery vehicles.Introduction. Advancements in treating autoimmune diseases such as multiple sclerosis (MS) have been made by enhancing our understanding of the molecular processes involved in disease progression. 1,2 The complexity of immune responses and the heterogeneous nature of immune cells complicate the design of therapeutics. In the case of relapsing-remitting MS, the disease state is propagated ...-Dr. Cory Berkland. Additional Information-Madison & Lila Self Graduate Fellow. Show More about Biography. 1132 Learned Hall 1530 W 15th St. Lawrence, KS 66045 Bus Route: 29 [email protected] 785-864-5258. facebook instagram twitter youtube linkedin. Admissions; Research Labs; People; Forms; Colloquium; School of Engineering; myKU; Visit KU; Apply ...Abdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USAWe identified Glatiramer Acetate (GA), a positively-charged polypeptide approved for multiple sclerosis, as a delivery agent capable of complexing with polyI:C or CpG and reducing the mobility of these actives. Small nanoparticles termed polyplexes form when mixing positively-charged GA and negatively-charged immunostimulant (polyI:C or …Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USACory Berkland Songyot Anuchapreeda: Authors: Singkome Tima Siriporn Okonogi Chadarat Ampasavate Chad Pickens Cory Berkland Songyot Anuchapreeda: Keywords: Pharmacology, Toxicology and Pharmaceutics: Issue Date: 1-Dec-2016: Abstract:Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and chemical properties. Biomaterials are also investigated for applications in regenerative medicine. Faculty Profile. Berkland Research Lab.Nabil A Alhakamy, Ph.D. candidate (Co-advised with Dr. Cory Berkland) Lorena Antunez, Ph.D. candidate (Co-advised with Dr. Cory Berkland) Aishik Chakraborty, Ph.D. student Saba Ghazvini, Ph.D. student Rachel Hathaway, M.S. Under-Graduate Students. Kimberley Cole Erica Hui Monica Ketchum ...Autoantigen-specific immunotherapy using peptides offers a more targeted approach to treat autoimmune diseases, but the limited in vivo stability and uptake of peptides impedes clinical implementation. We previously showed that multivalent delivery of peptides as soluble antigen arrays (SAgAs) efficiently protects against spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse model.Nashwa El-Gendy 1 , Kristin L Aillon, Cory Berkland. Affiliation 1 Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047, United States. PMID: 20214960 PMCID: PMC2859999 DOI: 10.1016/j.ijpharm.2010.03.009 Abstract Aerosolized contrast agents may improve the resolution of biomedical imaging modalities and enable ...Feb 14, 2022 · The company’s lead candidate, BBI-001, is an iron chelator for the treatment of hereditary hemochromatosis. Bond joins the St. Louis ecosystem after licensing technology originally developed at the University of Kansas. Bond was founded by St. Louisan and serial entrepreneur Cory Berkland, PhD. Zahra Mohammadi, Sun Shangbin, Cory Berkland, Jenn-tai Liang. Chelator-mimetic multi-functionalized hydrogel: Highly efficient and reusable sorbent for Cd, Pb, and As removal from waste water. Chemical Engineering Journal 2017 , 307 , 496-502.Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar]Abdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USAInstrumented Microphysiological Systems for Real-Time Measurement and Manipulation of Cellular Electrochemical Processes. Jonathan R. Soucy, Adam J. Bindas, Abigail N. Koppes, Ryan A. Koppes. Pages 521-548. View PDF.Cory Berkland The University of Kansas Lawrence, KS. Joel Bernstein New York University Abu Dhabi Abu Dhabi, United Arab Emirates. Michael Blaber Florida State University Tallahassee, FL. Robin H. Bogner University of Connecticut Storrs, CT. Kathleen MK Boje State University of Buffalo Amherst, NY.Cory BERKLAND | Cited by 10,026 | of University of Kansas, Kansas (KU) | Read 243 publications | Contact Cory BERKLANDGage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells ...BME Faculty Directory. Cardiovascular Engineering. Orthopedic Engineering. Women's Health Technologies.The aim of this project was to develop a gene replacement therapy for treating Charcot-Marie-Tooth disease type 4C to rescue the phenotype of the Sh3tc2-/- mouse model. We generated a lentiviral vector LV-Mpz.SH3TC2.myc to drive expression of the human SH3TC2 cDNA under the control of the Mpz promoter specifically in myelinating Schwann cells.As part of the BME seminar series, join us for this presentation by Cory Berkland, Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. This seminar will be virtual. Register for this event by going here. Abstract: Effective delivery of drugs to therapeutic targets requires an ...Cory Berkland. E-mail: [email protected]; Vladimir Birman Associate Professor of Chemistry McMillen 409. E-mail: [email protected]; Phone: 314-935-9188 John Bleeke Professor of Chemistry McMillen 501. E-mail: [email protected]; Phone: 314-935-6809 Robert CharityAbdulgader Baoum1, Sheng-Xue Xie1, Amir Fakhari2, and Cory Berkland1,3,4 1Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA 2Department of Bioengineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7. Globalization of Pharmaceutics Education Network (GPEN) Founded in 1996 by the KU Department of Pharmaceutical Chemistry in cooperation with several educational institutions in Europe and Asia, GPEN, Inc. was created for the sole purpose of fostering and facilitating international scientific exchange in the pharmaceutical sciences.He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. INTRODUCTION. Investigations into the molecular processes involved in antigen recognition have led to new approaches in the design and administration of vaccines (1, 2).Traditionally, vaccines generate a robust immune response to a particular antigen by adsorbing the antigen to an alum particle surface (3-5).Though individual alum particles are quite small (10-50 nm), in solution they form ...30‏/05‏/2018 ... 2012 Cory Berkland. 2011 Molly Stevens. 2010 Krish Roy. 2009 Justin Hanes. 2008 Samir Mitragotri. 2007 David Putnam. 2006 Stefaan De Smedt. 2005 ...Correspondence to: C. Berkland (e-mail: [email protected])Search for more papers by this author. Amir Fakhari, ... Search for more papers by this author. Cory Berkland, Corresponding Author. Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas.Cory Berkland, distinguished professor of pharmaceutical chemistry and chemical and petroleum engineering. This technology addresses a critical need to develop a more targeted immunotherapy to avoid unwanted immunosuppression and side effects. Antigen-drug conjugates use antigen epitopes specific to the autoimmune disease as agents to deliver ...Cory Berkland & Daniel W. Pack. Department of Electrical and Computer Engineering, University of Illinois, Urbana, Illinois, 61801. Kyekyoon (Kevin) Kim. Authors. Cory Berkland. View author publications. You can also search for this author in PubMed Google ...Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder CompactabilityCory Berkland The University of Kansas Verified email at ku.edu. Ayusman Sen Verne M. Willaman Professor of Chemistry, ... CJ Berkland, P Dhar. Langmuir 31 (14), 4232-4245, 2015. 34: 2015: A nondestructive tool for nanomaterials: Raman and photoluminescence spectroscopy. A Singha, P Dhar, A Roy. American journal of physics 73 (3), 224-233, 2005 ...Jakob M. Townsend, Brian T. Andrews, Yi Feng, Jinxi Wang, Randolph J. Nudo, Erik Van Kampen, Stevin H. Gehrke, Cory Berkland, Michael S. Detamore> ;Acta Biomaterialia. 2018 Apr 15 18 citations Effects of tissue processing on bioactivity of cartilage matrix-based hydrogels encapsulating osteoconductive particles.Cory Berkland, PhD. CEO, BOND BIOSCIENCES. Saint Louis, Missouri, United States. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a partial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development ...K-State News Kansas State University 128 Dole Hall 1525 Mid-Campus Dr North Manhattan, KS 66506. 785-532-2535 [email protected] combinations are gaining popularity because they provide convenience while enhancing patient compliance. Literature examples suggest that many fixed-dose combinations are being rationalized and investigated for their potential utility in therapy. This article provides an introspection int …Cory Berkland 1 , Martin King, Amanda Cox, Kyekyoon Kim, Daniel W Pack. Affiliation 1 Department of Chemical Engineering, University of Illinois, MC-712, Box C-3, 600 South Mathews Avenue, Urbana, IL 61801, USA. PMID: 12106984 PMCID: PMC4140625 DOI: 10.1016/s0168-3659(02 ...Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.Foothold Labs is working with Dr. Cory Berkland of with the University of Kansas Bioengineering & Pharmaceutical Chemistry Departments to explore the capabilities of electrochemical biosensing for pharmaceutical drug research and development purposes. Engenious Design . Engenious Design is a leading product development and engineering firm ...Cory Berkland Multiple sclerosis represents the world's most common cause of neurological disability in young people and is attributed to a loss of immune tolerance toward proteins of the myelin ...Cory Berkland. Connect About Experience Recommendations. Saint Louis, Missouri, United States. Interested in Entrepreneur Technologically Savvy. Orbis Biosciences - Aquired by Adare Pharmaceuticals in 2020 Savara Pharmaceuticals - NASDAQ listed in 2017. Experience.A cyclic peptide, cIBR, possesses high affinity for LFA-1, and conjugation to the surface of poly (DL-lactic-co-glycolic acid) nanoparticles can specifically target and deliver the encapsulated agents to T cells expressing LFA-1. The kinetics of targeted nanoparticle uptake by acute lymphoblastic leukemia T cells was investigated by flow ...Cory J Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, USA. Department of Pharmaceutical Chemistry, University of Kansas ...19‏/01‏/2021 ... Cory Berkland;. Cory Berkland. 2Department of Pharmaceutical Chemistry ... Cory Berkland,. Remi J. Creusot. Table S1 . List of antibodies used to ...The average moduli of the scaffolds, determined from the stress-strain plots using the end of the initial linear regions before the onset of the nonlinear region (the rationale for this will explained later), ranged from 71 to 196 kPa (Fig. 3), which may be suitable for cartilage tissue engineering applications.A higher intrinsic viscosity of the polymer, a decreased average diameter of the ...INTRODUCTION. Autoimmune diseases, such as multiple sclerosis (MS), 1, 2 type 1 diabetes (T1D), 3-7 neuromyelitis optica, 8, 9 and lupus erythematosus, 10, 11 involve loss of tolerance to self-antigens in autoreactive B cells, leading to tissue damage, disability, and death. In individuals afflicted by T1D, the insulin-producing beta cells in the pancreas are targeted by an autoimmune ...Jun 6, 2017 · INTRODUCTION. Autoimmune diseases such as multiple sclerosis (MS) are typified by a breakdown of healthy immune regulation and subsequent misrecognition of self for non-self. 1–2 The autoimmune breakdown in MS is largely propagated by autoreactive T and/or B cell clonal expansion and attack against myelin sheath autoantigens, leading to demyelination and neurodegeneration. 3–6 Activation ... Jun Yang, 1, 2 Sheng-Xue Xie, 3 Yiling Huang, 1, 4 Min Ling, 1 Jihong Liu, 2 Yali Ran, 1 Yanlin Wang, 4 J Brantley Thrasher, 1 Cory Berkland, 3 and Benyi Li *, 1, 4 Jun Yang 1 Department of Urology, The University of Kansas Medical Center, Kansas City, KS 66160, USA Dr. Hartwell obtained her Ph.D. in biomolecular engineering with Cory Berkland at the University of Kansas as a Madison and Lila Self Graduate Fellow. Her doctoral research focused on developing an antigen-specific immunotherapy to treat multiple sclerosis while determining cellular and molecular mechanisms of tolerance.Moderators: Dr. Cory Berkland and Dr. Omar Aljitawi 10-10:20 A.M. Dr. Cory Berkland Mimicking Properties of Natural Biomaterials as a Stem Cell Niche 10:20-10:40 A.M. Dr. Mei He 3D Printing Approaches to Creating Precise Cell Microenvironments 10:40-11 A.M. Dr. Wayne Godfrey YESCARTA (Axicabtagene Ciloleucel):Cory Berkland Solon E. Summerfield Distinguished Professor School of Pharmacy, Pharmaceutical Chemistry Contact Info Email: [email protected] Phone: 785-864-1455 320E Multidisciplinary Research Building Lawrence 2030 Becker Drive Lawrence, KS 66047 Personal Links Cory Berkland Research Education —Cory Berkland The University of Kansas Verified email at ku.edu. ... L Wang, CJ Berkland, MS Detamore. Annals of biomedical engineering 38, 2167-2182, 2010. 136: 2010: Bradley J. Newell. Interim Assistant Dean - Wichita. Director - PGY-1 Community-Based Pharmacy Residency (DIllons) Clinical Assistant Professor. School of Pharmacy - Administration. Department of Pharmacy Practice. Dept. of Family & Community Med., KU Med., Wichita. View full profile.Integrated Science Building (ISB) 1567 Irving Hill Road, Room 1140 Lawrence, KS 66045 [email protected] 785-864-4670Cory Berkland, PhD, has been developing microencapsulation and drug delivery capabilities for more than a decade. Cory has a PhD in Chemical and Biomolecular Engineering from the University of Illinois, Urbana-Champaign, where he co-invented and developed the Orbis technology. Cory is a Professor of Pharmaceutical Chemistry and Chemical and ...Cory Berkland The University of Kansas Verified email at ku.edu. Paulette Spencer Ackers Distinguished Professor, ... M Lazebnik, M Singh, P Glatt, LA Friis, CJ Berkland, MS Detamore. Journal of tissue engineering and regenerative medicine 5 (8), e179-e187, 2011. 80: 2011: Fatigue performance of composite analogue femur constructs under high ...Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Cory Berkland. The University of Kansas. Verified email at ku.edu. Drug Delivery Formulation Controlled Release. Articles Cited by Public access Co ... YY Lin, M Laird Forrest, CJ Berkland. Expert opinion on drug delivery 6 (11), 1175-1194, 2009. 461: 2009: Fabrication of PLG microspheres with precisely controlled and monodisperse size ...What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ...Cory Berkland; Iron overload is a critical clinical condition that can be controlled by diet and the use of iron-specific chelating agents. An effective oral formulation of an iron chelator should ...864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...See Free Details & Reputation Profile for Cory Berkland (47) in Lawrence, KS. Includes free contact info & photos & court records.Patent number: 11390795. Abstract: The invention is directed to delayed gelation agents comprising a degradable polymeric cage containing therein one or more gelation agents. The cage degrades in situ, e.g, in an oil reservoir, thus releasing the gelation agent (s), which can then crosslink second polymers in situ to form a gel. Type: Grant.Barlas Büyüktimkin, 1 Qun Wang, 2 Paul Kiptoo, 1 John M. Stewart, 1 Cory Berkland, 1, 2 and Teruna J. Siahaan 1, * Barlas Büyüktimkin 1 Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KSThat effort led to an NIH grant with Cory Berkland, Ph.D., of the University of Kansas, as principal investigator. Flash forward to present day and Detamore is a principal investigator of this current NIH project. Berkland, Dr. Brian Andrews, a surgeon who specializes in head and neck surgery at the University of Iowa Hospitals and Clinics, and ...Cory Berkland has 3 current jobs including Co-founder and Chief Executive Officer at Bond Biosciences, Co-founder and Chief Scientific Officer at Bond Biosciences, and Solon E. Summerfield Distinguished Professor at University of Kansas. Additionally, Cory Berkland has had 1 past job as the Chief Science/Scientist at Orbis Biosciences.Oct 9, 2014 · Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berkland C. Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro. Mol Pharm. 2013;11(1):367–73. doi: 10.1021/mp4003909. Acute B-Cell Inhibition by Soluble Antigen Arrays is Valency-Dependent and Predicts Immunomodulation in Splenocytes J. Daniel Griffin1, Martin A. Leon2, Jean R. Salash3, Michael Shao4, Brittany L. Hartwell1, Chad J. Pickens3, Joshua O. Sestak3, Cory Berkland1,3,4 1Bioengineering Graduate Program, University of Kansas, Lawrence, KS 2Department of Chemistry, University of Kansas, Lawrence, KSEl-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752–1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731–2746.Chad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States.Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States. 2 Department of Pharmaceutical Chemistry, University of Kansas 2095 Constant Avenue ...Tiffany C. Suekama, Vara Aziz, Zahra Mohammadi, Cory Berkland, Stevin H. Gehrke. Synthesis and characterization of poly( N -vinyl formamide) hydrogels-A potential alternative to polyacrylamide hydrogels. Journal of Polymer Science Part A: Polymer Chemistry 2013, 51 (2) , 435-445A method of forming particles comprises accelerating a stream comprising a liquid; and vibrating the stream, to form particles. The particle may have a diameter that is smaller than the diameter of the nozzle used to form the stream, allowing for the formation of micro- and nano-sized particle.Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.Cory Berkland Songyot Anuchapreeda: Authors: Singkome Tima Siriporn Okonogi Chadarat Ampasavate Chad Pickens Cory Berkland Songyot Anuchapreeda: Keywords: Pharmacology, Toxicology and Pharmaceutics: Issue Date: 1-Dec-2016: Abstract:Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors . Pharmaceutical Research . 2003 Jul 1;20(7):1055-1062. doi: 10.1023/A:1024466407849The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this o...Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Recently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...Chad Groer, 1 Ti Zhang, 1 Ruolin Lu, 2 Shuang Cai, 1 Derek Mull, 1 Aric Huang, 2 Melanie Forrest, 1 Cory Berkland, 2, 3 Daniel Aires, 1, 4 and Marcus Laird Forrest 1, 2, * Chad Groer 1 HylaPharm LLC, Lawrence, KansasINTRODUCTION. Investigations into the molecular processes involved in antigen recognition have led to new approaches in the design and administration of vaccines (1, 2).Traditionally, vaccines generate a robust immune response to a particular antigen by adsorbing the antigen to an alum particle surface (3-5).Though individual alum particles are quite small (10-50 nm), in solution they form ...I would like to sincerely and gratefully thank my advisor, Dr. Cory Berkland, for all of his support, guidance, patience, understanding, and most importantly, his friendship during my graduate studies at The University of Kansas. I have been fortunately blessed to have an advisor who gave me a great opportunity to develop my own individuality byCory Berkland. Drugs that can be used to diffuse iron overload exist, he said, but they are absorbed throughout the body, have "nasty" side effects and are really designed for other blood ...Cory Berkland The University of Kansas Verified email at ku.edu. Paulette Spencer Ackers Distinguished Professor, ... M Lazebnik, M Singh, P Glatt, LA Friis, CJ Berkland, MS Detamore. Journal of tissue engineering and regenerative medicine 5 (8), e179-e187, 2011. 80: 2011: Fatigue performance of composite analogue femur constructs under high ...Correspondence to: C. Berkland (e-mail: [email protected])Search for more papers by this author. Amir Fakhari, ... Search for more papers by this author. Cory Berkland, Corresponding Author. Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas.. Settimio Pacelli, Sayantani Basu, Jonathan WhitlNabil Alhakamy • Cory Berkland • Jin Chen • D Cory . Berkland. Vladimir . Birman Associate Professor of Chemistry John . Bleeke Professor of Chemistry Robert . Charity AU - Berkland, Cory. AU - Kim, Kyekyoon. AU - Pack, Daniel W. PY - 2003/7/1. Y1 - 2003/7/1. N2 - Purpose. Although the rate of drug release from poly(D,L-lactide-co-glycolide) (PLG) microspheres is often modulated by changing fabrication conditions or materials, the specific factors directly controlling the release profiles are often unclear. 09-Nov-2020. Durham, NC. 00000000. Evecxia. Executive Di Cory Berkland, Chief Executive Officer of Bond, commented that "we are highly encouraged by these results, which demonstrate the mechanism and clinical activity of BBI-001 after just a single dose. Diaz is a scholar in the IMSD program, an...

Continue Reading